Bayer AG (BAYZF)
50.93
+1.55
(+3.14%)
USD |
OTCM |
Oct 26, 16:00
Bayer Price to Book Value : 1.479 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.479 |
| October 23, 2026 | 1.434 |
| October 22, 2026 | 1.434 |
| October 21, 2026 | 1.434 |
| October 20, 2026 | 1.434 |
| October 19, 2026 | 1.417 |
| October 16, 2026 | 1.444 |
| October 15, 2026 | 1.452 |
| October 14, 2026 | 1.424 |
| October 13, 2026 | 1.424 |
| October 12, 2026 | 1.419 |
| October 09, 2026 | 1.425 |
| October 08, 2026 | 1.394 |
| October 07, 2026 | 1.468 |
| October 06, 2026 | 1.468 |
| October 05, 2026 | 1.437 |
| October 02, 2026 | 1.533 |
| October 01, 2026 | 1.453 |
| September 30, 2026 | 1.603 |
| September 29, 2026 | 1.608 |
| September 28, 2026 | 1.673 |
| September 25, 2026 | 1.646 |
| September 24, 2026 | 1.634 |
| September 23, 2026 | 1.649 |
| September 22, 2026 | 1.644 |
| Date | Value |
|---|---|
| September 21, 2026 | 1.630 |
| September 18, 2026 | 1.598 |
| September 17, 2026 | 1.638 |
| September 16, 2026 | 1.638 |
| September 15, 2026 | 1.668 |
| September 14, 2026 | 1.668 |
| September 11, 2026 | 1.641 |
| September 10, 2026 | 1.641 |
| September 09, 2026 | 1.641 |
| September 08, 2026 | 1.641 |
| September 04, 2026 | 1.641 |
| September 03, 2026 | 1.643 |
| September 02, 2026 | 1.643 |
| September 01, 2026 | 1.643 |
| August 31, 2026 | 1.636 |
| August 28, 2026 | 1.636 |
| August 27, 2026 | 1.636 |
| August 26, 2026 | 1.666 |
| August 25, 2026 | 1.666 |
| August 24, 2026 | 1.632 |
| August 21, 2026 | 1.625 |
| August 20, 2026 | 1.639 |
| August 19, 2026 | 1.586 |
| August 18, 2026 | 1.586 |
| August 17, 2026 | 1.586 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck KGaA | 2.021 |
| Breakthrough Chemistry, Inc. | 1.936 |
| Cardiac Biotech Solutions, Inc. | -- |
| Fresenius SE & Co. KGaA | 1.293 |
| Carl Zeiss Meditec AG | 3.575 |
Price to Book Value Related Metrics
| PS Ratio | 0.9454 |
| Price to Free Cash Flow | 56.41 |
| Price | 50.93 |
| Earnings Yield | -4.02% |
| Market Cap | 50.03B |
| Operating PE Ratio | 6.844 |
| Normalized PE Ratio | 25.78 |